Vascugenix
Little Rock
About Vascugenix
Vascugenix is a medical device company focused on developing innovative products to improve interventional cardiovascular procedures. Their first developed product, the Speed-Torque, is a device designed to improve the process of guidewire manipulation during Percutaneous Coronary and Peripheral Artery Interventions. It uses a unique, patented design to improve the process of guidewire manipulation during Percutaneous Coronary and Peripheral Artery Interventions. Vascugenix's unique, patented design enables physicians to manipulate a guidewire comfortably with one hand, freeing up the surgeon’s extra hand and enabling them to keep their full attention on the patient and the percutaneous guidewire rather than on the torque device. It provides physicians with the ability to manipulate catheter guidewires comfortably with one hand, allowing full attention to the patient and maintaining absolute control of the wire during the procedure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $545.0K
- Funding stage: Seed
- Last round: Convertible Note (May 2021)
- Website: vascugenix.com
- Phone: 5014421158
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/vascugenix-105249 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.